Obravnava endometrioze v pomenopavznem obdobju
Endometriosis management after menopause

slovenian

2023

volume 92, issue 11/12

endometriosis   malignant transfomation   meopause   oestrogen

Slovensko zdravniško društvo
(Obvezni izvod spletne publikacije)

Endometriosis is a disease that can affect 2-5% of all postmenopausal women. It is a disease in which the glands and stro-ma of the uterus are located outside the maternity area. To date, little is known in the literature about endometriosis in menopausal women. Diagnostic concerns currently relate mainly to concerns about possible malignancy. Reports in the literature describe the recurrence of endometriosis in the postmenopausal period as well as the occurrence of endome-triosis de novo. The treatment of choice for symptomatic endometriosis in menopause is the surgical removal of all visible endometriotic tissue, as the risk of recurrence and conversion to malignancy is relatively high. Postmenopausal hormone therapy (MHT) is often used to relieve postmenopausal symptoms and prevent bone loss. There are studies showing that MHZ can reactivate endometriotic foci and even promote malignant transformation of foci in women with a history of endometriosis. Considering the risks of MHZ in patients, which are not fully known, special caution should be exercised with this therapy.

05.04.2024